Загрузка...
Calcitonin gene-related peptide (receptor) antibodies: an exciting avenue for migraine treatment
Editorial summary Specific prophylactic migraine treatments are urgently needed because of the unmet needs of many migraine patients. Antibodies targeting calcitonin gene-related peptide (CGRP) or its receptor have recently shown efficacy in episodic and chronic migraine and will be available soon.
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMC
2018-02-01
|
| Серии: | Genome Medicine |
| Online-ссылка: | http://link.springer.com/article/10.1186/s13073-018-0524-7 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|